Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antineoplastic agent |
| gptkbp:alternativeName |
17-dimethylaminoethylamino-17-demethoxygeldanamycin
Alvespimycin |
| gptkbp:CASNumber |
467214-20-6
|
| gptkbp:category |
antitumor antibiotic
|
| gptkbp:clinicalTrialPhase |
investigational
|
| gptkbp:derivedFrom |
gptkb:geldanamycin
|
| gptkbp:hasMolecularFormula |
C32H48N4O8
|
| gptkbp:hasTherapeuticUse |
cancer treatment (investigational)
|
| https://www.w3.org/2000/01/rdf-schema#label |
17-DMAG
|
| gptkbp:mechanismOfAction |
Hsp90 inhibitor
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
heat shock protein 90 (Hsp90)
|
| gptkbp:bfsParent |
gptkb:geldanamycin
|
| gptkbp:bfsLayer |
8
|